Emergent Biosolutions Inc. EV/FCF

EV/FCF of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current EV/FCF of Emergent Biosolutions Inc. is -9.11 (as of December 31, 2022)
  • EV/FCF for the quarter ending June 30, 2023 was -3.31 (a -37.84% decrease compared to previous quarter)
  • Year-over-year quarterly EV/FCF decreased by -111.21%
  • Annual EV/FCF for 2022 was -9.11 (a -133.79% decrease from previous year)
  • Annual EV/FCF for 2021 was 26.95 (a 113.78% increase from previous year)
  • Annual EV/FCF for 2020 was 12.61 (a -62.75% decrease from previous year)
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of Emergent Biosolutions Inc.

Most recent EV/FCFof EBS including historical data for past 10 years.

Interactive Chart of EV/FCF of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. EV/FCF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -3.31 -5.32 – – –
2022 -9.11 29.52 15.95 31.94 -9.11
2021 26.95 136.84 31.29 16.96 26.95
2020 12.61 21.85 24.14 70.49 12.61
2019 33.85 -19.72 -585.14 46.51 33.85
2018 -131.85 13.12 24.66 19.81 -131.85
2017 12.01 28.99 30.46 -48.1 12.01
2016 -60.88 1285.05 12.82 13.93 -60.88
2015 -647.17 24.19 49.53 27.84 -647.17
2014 12.12 17.28 71.13 30.72 12.12
2013 13.09 290.97 -319.59 -23.26 13.09
2012 -205.1 5.85 – – -205.1

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com